Treatment of viral infections using the L-isomer of ribavirin
US6518253B1 · kind B1 · utility
9Cited by
3References
12Claims
0Family size
Inventor
Key dates
| Filing date | Dec 23, 1999 |
| Grant date | Feb 11, 2003 |
| Priority date | — |
| Expiry date | Dec 23, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/056
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A 1-(&bgr;-L-ribofuranosyl)-1,2,4-triazole-3-carboxamide is administered in a method of treatment of a viral infection in a patient, including HIV infection, HCV infection, or BHV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.